ArticleAnnals of medicine and surgery (2012)2025

FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option.

Chukwuka Elendu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.